TMCO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.775360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.254000E-01
Normal-vs-Stage2
1.835350E-01
Normal-vs-Stage3
6.693400E-01
Normal-vs-Stage4
1.873620E-01
Stage1-vs-Stage2
1.780770E-01
Stage1-vs-Stage3
2.348600E-01
Stage1-vs-Stage4
9.829000E-01
Stage2-vs-Stage3
4.049400E-01
Stage2-vs-Stage4
2.835600E-01
Stage3-vs-Stage4
3.171200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.101800E-01
Normal-vs-AfricanAmerican
6.747600E-02
Normal-vs-Asian
1.088980E-01
Caucasian-vs-AfricanAmerican
5.859800E-02
Caucasian-vs-Asian
4.247700E-02
AfricanAmerican-vs-Asian
8.218600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.910430E-01
Normal-vs-Female
1.721440E-01
Male-vs-Female
9.324000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.441000E-01
Normal-vs-Age(41-60Yrs)
7.990000E-02
Normal-vs-Age(61-80Yrs)
2.552400E-01
Normal-vs-Age(81-100Yrs)
1.912590E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.203800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.695200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.174200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.246370E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.598600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.403600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.311800E-01
Normal-vs-Daily Drinker
4.566200E-01
Normal-vs-Weekly Drinker
2.369400E-01
Normal-vs-Occasional Drinker
2.480000E-02
Normal-vs-Social Drinker
1.991580E-01
Non Drinker-vs-Daily Drinker
2.853800E-01
Non Drinker-vs-Weekly Drinker
8.964400E-01
Non Drinker-vs-Occasional Drinker
1.515760E-01
Non Drinker-vs-Social Drinker
7.195600E-01
Daily Drinker-vs-Weekly Drinker
3.438800E-01
Daily Drinker-vs-Occasional Drinker
5.700700E-03
Daily Drinker-vs-Social Drinker
4.110200E-01
Weekly Drinker-vs-Occasional Drinker
1.146770E-01
Weekly Drinker-vs-Social Drinker
8.458000E-01
Occasional Drinker-vs-Social Drinker
5.073700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.594000E-02
Normal-vs-Grade 2
9.435600E-03
Normal-vs-Grade 3
1.022370E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.074600E-01
Grade 1-vs-Grade 3
4.712600E-01
Grade 1-vs-Grade 4
4.594000E-02
Grade 2-vs-Grade 3
8.484200E-01
Grade 2-vs-Grade 4
9.435600E-03
Grade 3-vs-Grade 4
1.022370E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.262000E-01
Normal-vs-NonDiabetic
1.168970E-01
Diabetic-vs-NonDiabetic
8.604300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.779400E-01
Normal-vs-NoPancreatitis
1.917580E-01
Pancreatitis-vs-NoPancreatitis
8.474600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.146980E-01
Normal-vs-N1
2.101000E-01
N0-vs-N1
6.095700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.261500E-02
Normal-vs-TP53-NonMutant
1.860840E-01
TP53-Mutant-vs-TP53-NonMutant
1.121990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
